Therapeutic extended reality platform XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets, including its main product, Koji's Quest.

Boston-based XRHealth offers a catalog of immersive medical extended reality (XR) experiences focused on the physical and cognitive space, including symptom management, meditation exercises, upper extremity rehabilitation, cognitive training and fitness-focused offerings. 

NeuroReality offers cognitive training virtual reality tools, including its Koji Quest experience, which provides customizable programs addressing rehabilitation needs from stroke, long COVID, traumatic brain injury, neurodevelopmental issues, neurodegenerative issues and dementia, and healthy aging.  

"The acquisition of NeuroReality and its flagship product, Koji's Quest, represents another leap forward in our mission to provide the most comprehensive XR therapeutic platform available. We are focused on creating a transformative experience for patients and clinicians alike, and Koji's Quest will allow us to offer an even richer, more engaging set of tools for therapy and rehabilitation," Eran Orr, CEO of XRHealth, said in a statement.

THE LARGER TREND

XRHealth is a significant player in the medical XR space. In a LinkedIn post, Orr said the company is "building the biggest XR in healthcare platform in the world."

Earlier this year, the company secured $6 million in funding, two years after scoring $10 million to expand VR-focused healthcare treatment in the metaverse.  

In 2020, XRHealth garnered $7 million in funding and a $450,000 grant from the Israeli Innovation Authority to provide hospitals in Israel with telehealth services to combat the effects of COVID-19. 

Last year, the company acquired Barcelona-based Amelia Virtual Care, a VR platform for mental health professionals, and announced its intention to merge into one company under the XRHealth brand name. The company allowed providers to connect directly with patients via the platform but has since pulled out of the direct-to-provider space. 

XRHealth also revealed plans to send a VR headset into space to support astronauts' mental health.

In collaboration with VR headset maker HTC Vive and Nord-Space Aps, XRHealth engineered the Vive Focus 3 headset to withstand the conditions of space by using a simulator mode and specialized tracking methodology through the controllers to ensure effective operation in a microgravity environment.

The company was awarded a U.S. patent for a learning system technology that adjusts training and treatment protocols according to a patient's biometric and motion data.

The technology would be used to combine Apple Watch and Apple's augmented reality headset, Apple Vision Pro, to provide closed-loop AI-enabled treatment.